Pro Medicus Shares Owned By Insiders vs. EBITDA
| PME Stock | 250.19 5.25 2.06% |
For Pro Medicus profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Pro Medicus to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Pro Medicus utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Pro Medicus's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Pro Medicus over time as well as its relative position and ranking within its peers.
Pro |
Pro Medicus EBITDA vs. Shares Owned By Insiders Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Pro Medicus's current stock value. Our valuation model uses many indicators to compare Pro Medicus value to that of its competitors to determine the firm's financial worth. Pro Medicus is considered to be number one stock in shares owned by insiders category among its peers. It also is considered to be number one stock in ebitda category among its peers totaling about 2,450,528 of EBITDA per Shares Owned By Insiders. At this time, Pro Medicus' EBITDA is comparatively stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pro Medicus' earnings, one of the primary drivers of an investment's value.Pro EBITDA vs. Shares Owned By Insiders
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Pro Medicus |
| = | 49.28 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Pro Medicus |
| = | 120.76 M |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Pro EBITDA Comparison
Pro Medicus is currently under evaluation in ebitda category among its peers.
Pro Medicus Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Pro Medicus, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Pro Medicus will eventually generate negative long term returns. The profitability progress is the general direction of Pro Medicus' change in net profit over the period of time. It can combine multiple indicators of Pro Medicus, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -9.3 M | -8.8 M | |
| Operating Income | 112.2 M | 117.8 M | |
| Income Before Tax | 116.5 M | 122.3 M | |
| Total Other Income Expense Net | 4.3 M | 4.5 M | |
| Net Income | 82.8 M | 86.9 M | |
| Income Tax Expense | 33.7 M | 35.4 M | |
| Net Income Applicable To Common Shares | 69.7 M | 73.2 M | |
| Net Income From Continuing Ops | 82.8 M | 86.9 M | |
| Net Interest Income | 4.8 M | 5.1 M | |
| Interest Income | 4.8 M | 5.1 M | |
| Change To Netincome | -276 K | -262.2 K |
Pro Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Pro Medicus. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Pro Medicus position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Pro Medicus' important profitability drivers and their relationship over time.
Use Pro Medicus in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Pro Medicus position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pro Medicus will appreciate offsetting losses from the drop in the long position's value.Pro Medicus Pair Trading
Pro Medicus Pair Trading Analysis
The ability to find closely correlated positions to Pro Medicus could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pro Medicus when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pro Medicus - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pro Medicus to buy it.
The correlation of Pro Medicus is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pro Medicus moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pro Medicus moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Pro Medicus can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Pro Medicus position
In addition to having Pro Medicus in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Silver Thematic Idea Now
Silver
Companies involved in mining, production, and distribution of silver and silver goods. The Silver theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Silver Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Pro Stock Analysis
When running Pro Medicus' price analysis, check to measure Pro Medicus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pro Medicus is operating at the current time. Most of Pro Medicus' value examination focuses on studying past and present price action to predict the probability of Pro Medicus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pro Medicus' price. Additionally, you may evaluate how the addition of Pro Medicus to your portfolios can decrease your overall portfolio volatility.